Showing results (1501-1510 of 1,628) with videos related to

Sort By:
Pageof 163
Ejhaem|December 18, 2025
Development of Machine-Assisted, Human-Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic SyndromesKiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, et al.
Blood|July 30, 2010
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translationAlexa S Green, Nicolas Chapuis, Thiago Trovati Maciel, et al.
Poultry Science|June 26, 2019
Dietary methionine deficiency reduces laying performances of female common ducks and impacts traits of interest of their mule ducklingsL Bodin, A Sécula, H Chapuis, et al.
AIDS (London, England)|September 21, 2000
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapyP A Bart, G P Rizzardi, G Tambussi, et al.
Cancer Immunology Research|March 18, 2020
Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell CarcinomasLichen Jing, Mariliis Ott, Candice D Church, et al.
Nature Communications|December 22, 2018
A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subsetDorothée Selimoglu-Buet, Julie Rivière, Hussein Ghamlouch, et al.
Plos Computational Biology|April 28, 2025
Unlocking the soundscape of coral reefs with artificial intelligence: pretrained networks and unsupervised learning win outBen Williams, Santiago M Balvanera, Sarab S Sethi, et al.
FEBS Letters|May 27, 2008
Spatial and temporal down-regulation of transgene expression using the TRSID-silencer in mice: application to PrnpMicaela Gallozzi, Vincent Béringue, Pauline Decaunes, et al.
Blood|November 19, 2016
Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromesVirginie Chesnais, Marie-Laure Arcangeli, Caroline Delette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor RegressionAude G Chapuis, Ilana M Roberts, John A Thompson, et al.
Pageof 163